Pankalma en es it fr

Pankalma Brand names, Pankalma Analogs

Pankalma Brand Names Mixture

  • No information avaliable

Pankalma Chemical_Formula


Pankalma RX_link

No information avaliable

Pankalma fda sheet

Pankalma msds (material safety sheet)

Pankalma Synthesis Reference

No information avaliable

Pankalma Molecular Weight

309.469 g/mol

Pankalma Melting Point

< 25 oC

Pankalma H2O Solubility

Soluble as HCl salt

Pankalma State


Pankalma LogP


Pankalma Dosage Forms

Tablets (oral, 1 mg)

Pankalma Indication

Used for the symptomatic treatment of parkinsonism.

Pankalma Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Pankalma Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Pankalma side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Pankalma Patient Information

Pankalma Organisms Affected

Humans and other mammals